Skip to content

U.S. backs WTO deadline extension on patent waivers for COVID-19

WTO has long deadlocked over a proposed annual waiver of parts of a major intellectual property agreement.

The U.S. announced support for extending a key WTO deadline on COVID-19 diagnostics and therapeutics.
The U.S. announced support for extending a key WTO deadline on COVID-19 diagnostics and therapeutics. (AN/Mufid Majnun / Unsplash)

The United States refuses to agree to patent waivers for COVID-19 tests and treatments this year, saying more information is needed to make a sound decision.

The Office of the U.S. Trade Representative announced its support on Tuesday for trade ministers putting off a decision on the World Trade Organization's long-running debate over a waiver for some intellectual property protections.

Get full Free+ access with a free subscription

Join now

Already have an account? Log in

Latest